Jacques Tremblay - Publications

Affiliations: 
1975 University of California, San Diego, La Jolla, CA 

149 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2015 Tremblay JP. [The CRISPR system can correct or modify the expression of genes responsible for hereditary diseases]. MéDecine Sciences : M/S. 31: 1014-22. PMID 26576609 DOI: 10.1051/medsci/20153111016  0.76
2015 Skuk D, Tremblay JP. Cell therapy in muscular dystrophies: many promises in mice and dogs, few facts in patients. Expert Opinion On Biological Therapy. 1-13. PMID 26076715 DOI: 10.1517/14712598.2015.1057564  0.76
2015 Filali M, Lalonde R, Gérard C, Coulombe Z, Tremblay JP. Sensorimotor skills in Fxn KO/Mck mutants deficient for frataxin in muscle. Brain Research. 1608: 91-6. PMID 25765157 DOI: 10.1016/j.brainres.2015.03.001  0.76
2014 Lee EJ, Kim AY, Lee EM, Lee MM, Min CW, Kang KK, Park JK, Hwang M, Kwon SH, Tremblay JP, Jeong KS. Therapeutic effects of exon skipping and losartan on skeletal muscle of mdx mice. Pathology International. 64: 388-96. PMID 25143127 DOI: 10.1111/pin.12190  0.76
2014 Skuk D, Tremblay JP. Clarifying misconceptions about myoblast transplantation in myology. Molecular Therapy : the Journal of the American Society of Gene Therapy. 22: 897-8. PMID 24787976 DOI: 10.1038/mt.2014.57  0.76
2014 Lacroix Pépin N, Chapdelaine P, Rodriguez Y, Tremblay JP, Fortier MA. Generation of human endometrial knockout cell lines with the CRISPR/Cas9 system confirms the prostaglandin F2α synthase activity of aldo-ketoreductase 1B1. Molecular Human Reproduction. 20: 650-63. PMID 24674991 DOI: 10.1093/molehr/gau023  0.76
2014 Tremblay JP, Aartsma-Rus A, Bogdanove A, Ferreira MB, Bueren J, Huard J. Development of a web course on gene therapy by the international consortium of gene therapy. Molecular Therapy : the Journal of the American Society of Gene Therapy. 22: 482. PMID 24584076 DOI: 10.1038/mt.2014.11  0.76
2014 Skuk D, Goulet M, Tremblay JP. Intramuscular transplantation of myogenic cells in primates: importance of needle size, cell number, and injection volume. Cell Transplantation. 23: 13-25. PMID 23294849 DOI: 10.3727/096368912X661337  0.76
2014 Skuk D, Tremblay JP. Transplantation of Myogenic Cells in Duchenne Muscular Dystrophy Patients: Clinical Findings Translational Regenerative Medicine. 345-355. DOI: 10.1016/B978-0-12-410396-2.00026-8  0.76
2013 Chapdelaine P, Coulombe Z, Chikh A, Gérard C, Tremblay JP. A Potential New Therapeutic Approach for Friedreich Ataxia: Induction of Frataxin Expression With TALE Proteins. Molecular Therapy. Nucleic Acids. 2: e119. PMID 24002729 DOI: 10.1038/mtna.2013.41  0.76
2013 Skuk D, Goulet M, Tremblay JP. Electroporation as a method to induce myofiber regeneration and increase the engraftment of myogenic cells in skeletal muscles of primates. Journal of Neuropathology and Experimental Neurology. 72: 723-34. PMID 23860026 DOI: 10.1097/NEN.0b013e31829bac22  0.76
2013 Ousterout DG, Perez-Pinera P, Thakore PI, Kabadi AM, Brown MT, Qin X, Fedrigo O, Mouly V, Tremblay JP, Gersbach CA. Reading frame correction by targeted genome editing restores dystrophin expression in cells from Duchenne muscular dystrophy patients. Molecular Therapy : the Journal of the American Society of Gene Therapy. 21: 1718-26. PMID 23732986 DOI: 10.1038/mt.2013.111  0.76
2013 Hogrel JY, Zagnoli F, Canal A, Fraysse B, Bouchard JP, Skuk D, Fardeau M, Tremblay JP. Assessment of a symptomatic Duchenne muscular dystrophy carrier 20 years after myoblast transplantation from her asymptomatic identical twin sister. Neuromuscular Disorders : Nmd. 23: 575-9. PMID 23731976 DOI: 10.1016/j.nmd.2013.04.007  0.76
2013 Benabdallah BF, Duval A, Rousseau J, Chapdelaine P, Holmes MC, Haddad E, Tremblay JP, Beauséjour CM. Targeted Gene Addition of Microdystrophin in Mice Skeletal Muscle via Human Myoblast Transplantation. Molecular Therapy. Nucleic Acids. 2: e68. PMID 23360951 DOI: 10.1038/mtna.2012.55  0.76
2013 Skuk D, Goulet M, Paradis M, Tremblay JP. Myopathy in a rhesus monkey with biopsy findings similar to human sporadic inclusion body myositis. Neuromuscular Disorders : Nmd. 23: 155-9. PMID 23200905 DOI: 10.1016/j.nmd.2012.10.020  0.76
2013 Kim AY, Lee EM, Lee EJ, Min CW, Kang KK, Park JK, Hong IH, Ishigami A, Tremblay JP, Jeong KS. Effects of vitamin C on cytotherapy-mediated muscle regeneration. Cell Transplantation. 22: 1845-58. PMID 23051044 DOI: 10.3727/096368912X657846  0.76
2013 Skuk D, Tremblay JP. Myoblast Transplantation in Skeletal Muscles Handbook of Stem Cells. 2: 653-664. DOI: 10.1016/B978-0-12-385942-6.00057-3  0.76
2012 Robert MA, Zeng Y, Raymond B, Desfossé L, Mairey E, Tremblay JP, Massie B, Gilbert R. Efficacy and site-specificity of adenoviral vector integration mediated by the phage φC31 integrase. Human Gene Therapy Methods. 23: 393-407. PMID 23194172 DOI: 10.1089/hgtb.2012.122  0.76
2012 Lesault PF, Theret M, Magnan M, Cuvellier S, Niu Y, Gherardi RK, Tremblay JP, Hittinger L, Chazaud B. Macrophages improve survival, proliferation and migration of engrafted myogenic precursor cells into MDX skeletal muscle. Plos One. 7: e46698. PMID 23056408 DOI: 10.1371/journal.pone.0046698  0.76
2012 Goudenege S, Lebel C, Huot NB, Dufour C, Fujii I, Gekas J, Rousseau J, Tremblay JP. Myoblasts derived from normal hESCs and dystrophic hiPSCs efficiently fuse with existing muscle fibers following transplantation. Molecular Therapy : the Journal of the American Society of Gene Therapy. 20: 2153-67. PMID 22990676 DOI: 10.1038/mt.2012.188  0.76
2012 Gérard C, Dufour C, Goudenege S, Skuk D, Tremblay JP. AG490 improves the survival of human myoblasts in vitro and in vivo. Cell Transplantation. 21: 2665-76. PMID 22963730 DOI: 10.3727/096368912X655028  0.76
2012 Skuk D, Tremblay JP. Necrosis, sarcolemmal damage and apoptotic events in myofibers rejected by CD8+ lymphocytes: Observations in nonhuman primates. Neuromuscular Disorders : Nmd. 22: 997-1005. PMID 22749896 DOI: 10.1016/j.nmd.2012.05.005  0.76
2012 Tremblay JP, Chapdelaine P, Coulombe Z, Rousseau J. Transcription activator-like effector proteins induce the expression of the frataxin gene. Human Gene Therapy. 23: 883-90. PMID 22587705 DOI: 10.1089/hum.2012.034  0.76
2012 Fakhfakh R, Lee SJ, Tremblay JP. Administration of a soluble activin type IIB receptor promotes the transplantation of human myoblasts in dystrophic mice. Cell Transplantation. 21: 1419-30. PMID 22449443 DOI: 10.3727/096368911X627480  0.76
2012 Pichavant C, Tremblay JP. Generation of lentiviral vectors for use in skeletal muscle research. Methods in Molecular Biology (Clifton, N.J.). 798: 285-95. PMID 22130843 DOI: 10.1007/978-1-61779-343-1_16  0.76
2012 Fakhfakh R, Lamarre Y, Skuk D, Tremblay JP. Losartan enhances the success of myoblast transplantation. Cell Transplantation. 21: 139-52. PMID 21535912 DOI: 10.3727/096368911X576045  0.76
2012 Gerard C, Forest MA, Beauregard G, Skuk D, Tremblay JP. Fibrin gel improves the survival of transplanted myoblasts. Cell Transplantation. 21: 127-37. PMID 21535909 DOI: 10.3727/096368911X576018  0.76
2011 Tremblay JP, Frederickson RM. Gene transfer using HACs: a key step closer to ex vivo gene therapy using autologous gene-corrected cells to treat muscular dystrophy. Molecular Therapy : the Journal of the American Society of Gene Therapy. 19: 2111-3. PMID 22134745 DOI: 10.1038/mt.2011.254  0.76
2011 Pichavant C, Gargioli C, Tremblay JP. Intramuscular Transplantation of Muscle Precursor Cells over-expressing MMP-9 improves Transplantation Success. Plos Currents. 3: RRN1275. PMID 22052037 DOI: 10.1371/currents.RRN1275  0.76
2011 Rousseau J, Chapdelaine P, Boisvert S, Almeida LP, Corbeil J, Montpetit A, Tremblay JP. Endonucleases: tools to correct the dystrophin gene. The Journal of Gene Medicine. 13: 522-37. PMID 21954090 DOI: 10.1002/jgm.1611  0.76
2011 Skuk D, Goulet M, Tremblay JP. Transplanted myoblasts can migrate several millimeters to fuse with damaged myofibers in nonhuman primate skeletal muscle. Journal of Neuropathology and Experimental Neurology. 70: 770-8. PMID 21865885 DOI: 10.1097/NEN.0b013e31822a6baa  0.76
2011 Pichavant C, Aartsma-Rus A, Clemens PR, Davies KE, Dickson G, Takeda S, Wilton SD, Wolff JA, Wooddell CI, Xiao X, Tremblay JP. Current status of pharmaceutical and genetic therapeutic approaches to treat DMD. Molecular Therapy : the Journal of the American Society of Gene Therapy. 19: 830-40. PMID 21468001 DOI: 10.1038/mt.2011.59  0.76
2011 Skuk D, Tremblay JP. Intramuscular cell transplantation as a potential treatment of myopathies: clinical and preclinical relevant data. Expert Opinion On Biological Therapy. 11: 359-74. PMID 21204740 DOI: 10.1517/14712598.2011.548800  0.76
2011 Tremblay JP, Skuk D, Frederickson R. Not an inside job: how can transplantation of relatively few exogenous satellite cells do what thousands of endogenous cells cannot? Molecular Therapy : the Journal of the American Society of Gene Therapy. 19: 6-8. PMID 21200393 DOI: 10.1038/mt.2010.276  0.76
2011 Fakhfakh R, Michaud A, Tremblay JP. Blocking the myostatin signal with a dominant negative receptor improves the success of human myoblast transplantation in dystrophic mice. Molecular Therapy : the Journal of the American Society of Gene Therapy. 19: 204-10. PMID 20700111 DOI: 10.1038/mt.2010.171  0.76
2010 Palmieri B, Tremblay JP, Daniele L. Past, present and future of myoblast transplantation in the treatment of Duchenne muscular dystrophy. Pediatric Transplantation. 14: 813-9. PMID 20963914 DOI: 10.1111/j.1399-3046.2010.01377.x  0.76
2010 Palmieri B, Tremblay JP. Myoblast transplantation: a possible surgical treatment for a severe pediatric disease. Surgery Today. 40: 902-8. PMID 20872191 DOI: 10.1007/s00595-009-4242-z  0.76
2010 Goudenege S, Lamarre Y, Dumont N, Rousseau J, Frenette J, Skuk D, Tremblay JP. Laminin-111: a potential therapeutic agent for Duchenne muscular dystrophy. Molecular Therapy : the Journal of the American Society of Gene Therapy. 18: 2155-63. PMID 20683444 DOI: 10.1038/mt.2010.165  0.76
2010 Rousseau J, Dumont N, Lebel C, Quenneville SP, Côté CH, Frenette J, Tremblay JP. Dystrophin expression following the transplantation of normal muscle precursor cells protects mdx muscle from contraction-induced damage. Cell Transplantation. 19: 589-96. PMID 20650035 DOI: 10.3727/096368910X4863235  0.76
2010 Skuk D, Paradis M, Goulet M, Chapdelaine P, Rothstein DM, Tremblay JP. Intramuscular transplantation of human postnatal myoblasts generates functional donor-derived satellite cells. Molecular Therapy : the Journal of the American Society of Gene Therapy. 18: 1689-97. PMID 20606644 DOI: 10.1038/mt.2010.128  0.76
2010 Maltais S, Tremblay JP, Perrault LP, Ly HQ. The paracrine effect: pivotal mechanism in cell-based cardiac repair. Journal of Cardiovascular Translational Research. 3: 652-62. PMID 20559770 DOI: 10.1007/s12265-010-9198-2  0.76
2010 Pichavant C, Chapdelaine P, Cerri DG, Bizario JC, Tremblay JP. Electrotransfer of the full-length dog dystrophin into mouse and dystrophic dog muscles. Human Gene Therapy. 21: 1591-601. PMID 20553115 DOI: 10.1089/hum.2010.024  0.76
2010 Chapdelaine P, Pichavant C, Rousseau J, Pâques F, Tremblay JP. Meganucleases can restore the reading frame of a mutated dystrophin Gene Therapy. 17: 846-858. PMID 20393509 DOI: 10.1038/gt.2010.26  0.76
2010 Paccalet T, Coulombe Z, Tremblay JP. Ganglioside GM3 levels are altered in a mouse model of HIBM: GM3 as a cellular marker of the disease. Plos One. 5: e10055. PMID 20383336 DOI: 10.1371/journal.pone.0010055  0.76
2010 Richard PL, Gosselin C, Laliberté T, Paradis M, Goulet M, Tremblay JP, Skuk D. A first semimanual device for clinical intramuscular repetitive cell injections. Cell Transplantation. 19: 67-78. PMID 20370989 DOI: 10.3727/096368909X478812  0.76
2010 Pichavant C, Chapdelaine P, Cerri DG, Dominique JC, Quenneville SP, Skuk D, Kornegay JN, Bizario JC, Xiao X, Tremblay JP. Expression of dog microdystrophin in mouse and dog muscles by gene therapy. Molecular Therapy : the Journal of the American Society of Gene Therapy. 18: 1002-9. PMID 20179674 DOI: 10.1038/mt.2010.23  0.76
2010 Skuk D, Goulet M, Tremblay JP. Preservation of muscle spindles in a 27-year-old Duchenne muscular dystrophy patient: importance for regenerative medicine strategies. Muscle & Nerve. 41: 729-30. PMID 20151468 DOI: 10.1002/mus.21644  0.76
2010 Larose E, Proulx G, Voisine P, Rodés-Cabau J, De Larochellière R, Rossignol G, Bertrand OF, Tremblay JP. Percutaneous versus surgical delivery of autologous myoblasts after chronic myocardial infarction: an in vivo cardiovascular magnetic resonance study. Catheterization and Cardiovascular Interventions : Official Journal of the Society For Cardiac Angiography & Interventions. 75: 120-7. PMID 19859959 DOI: 10.1002/ccd.22204  0.76
2009 Tremblay JP, Skuk D, Palmieri B, Rothstein DM. A case for immunosuppression for myoblast transplantation in duchenne muscular dystrophy. Molecular Therapy : the Journal of the American Society of Gene Therapy. 17: 1122-4. PMID 19564866 DOI: 10.1038/mt.2009.125  0.76
2009 Lafreniere JF, Caron MC, Skuk D, Goulet M, Cheikh AR, Tremblay JP. Growth factor coinjection improves the migration potential of monkey myogenic precursors without affecting cell transplantation success. Cell Transplantation. 18: 719-30. PMID 19523340 DOI: 10.3727/096368909X470900  0.76
2009 Benabdallah BF, Bouchentouf M, Rousseau J, Tremblay JP. Overexpression of follistatin in human myoblasts increases their proliferation and differentiation, and improves the graft success in SCID mice Cell Transplantation. 18: 709-718. PMID 19520047 DOI: 10.3727/096368909X470865  0.76
2009 Krishnaswamy N, Chapdelaine P, Tremblay JP, Fortier MA. Development and characterization of a simian virus 40 immortalized bovine endometrial stromal cell line. Endocrinology. 150: 485-91. PMID 18772234 DOI: 10.1210/en.2008-0744  0.76
2008 Tremblay JP, Skuk D. Another new "super muscle stem cell" leaves unaddressed the real problems of cell therapy for duchenne muscular dystrophy. Molecular Therapy : the Journal of the American Society of Gene Therapy. 16: 1907-9. PMID 19023271 DOI: 10.1038/mt.2008.243  0.76
2008 Camirand G, Stéphan L, Rousseau J, Sackett MK, Caron NJ, Mills P, Kurtz J, Sykes M, Rothstein DM, Tremblay JP. Central tolerance to myogenic cell transplants does not include muscle neoantigens. Transplantation. 85: 1791-801. PMID 18580473 DOI: 10.1097/TP.0b013e31817726bc  0.76
2008 Benabdallah BF, Bouchentouf M, Rousseau J, Bigey P, Michaud A, Chapdelaine P, Scherman D, Tremblay JP. Inhibiting myostatin with follistatin improves the success of myoblast transplantation in dystrophic mice Cell Transplantation. 17: 337-350. PMID 18522236  0.76
2008 Hering BJ, Sykes M, Sutherland DER, Shapiro AMJ, Tremblay JP. Preface Transplantation Proceedings. 40: 335-336. PMID 18374060 DOI: 10.1016/j.transproceed.2008.02.021  0.76
2008 Bouchentouf M, Benabdallah BF, Bigey P, Yau TM, Scherman D, Tremblay JP. Vascular endothelial growth factor reduced hypoxia-induced death of human myoblasts and improved their engraftment in mouse muscles Gene Therapy. 15: 404-414. PMID 18079754 DOI: 10.1038/sj.gt.3303059  0.76
2008 Skuk D, Tremblay JP. Implantation of Myogenic Cells in Skeletal Muscles Principles of Regenerative Medicine. 782-793. DOI: 10.1016/B978-012369410-2.50048-6  0.76
2007 Skuk D, Paradis M, Goulet M, Tremblay JP. Ischemic central necrosis in pockets of transplanted myoblasts in nonhuman primates: implications for cell-transplantation strategies. Transplantation. 84: 1307-15. PMID 18049116 DOI: 10.1097/01.tp.0000288322.94252.22  0.76
2007 Mills P, Dominique JC, Lafrenière JF, Bouchentouf M, Tremblay JP. A synthetic mechano growth factor E peptide enhances myogenic precursor cell transplantation success American Journal of Transplantation. 7: 2247-2259. PMID 17845560 DOI: 10.1111/j.1600-6143.2007.01927.x  0.76
2007 Stephan L, Bouchentouf M, Mills P, Lafreniere JF, Tremblay JP. 1,25-Dihydroxyvitamin D3 increases the transplantation success of human muscle precursor cells in SCID mice Cell Transplantation. 16: 391-402. PMID 17658129  0.76
2007 Bouchentouf M, Benabdallah BF, Rousseau J, Schwartz LM, Tremblay JP. Induction of Anoikis following myoblast transplantation into SCID mouse muscles requires the Bit1 and FADD pathways. American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons. 7: 1491-505. PMID 17511679 DOI: 10.1111/j.1600-6143.2007.01830.x  0.76
2007 Péault B, Rudnicki M, Torrente Y, Cossu G, Tremblay JP, Partridge T, Gussoni E, Kunkel LM, Huard J. Stem and progenitor cells in skeletal muscle development, maintenance, and therapy. Molecular Therapy : the Journal of the American Society of Gene Therapy. 15: 867-77. PMID 17387336 DOI: 10.1038/mt.sj.6300145  0.76
2007 Quenneville SP, Chapdelaine P, Skuk D, Paradis M, Goulet M, Rousseau J, Xiao X, Garcia L, Tremblay JP. Autologous transplantation of muscle precursor cells modified with a lentivirus for muscular dystrophy: human cells and primate models. Molecular Therapy : the Journal of the American Society of Gene Therapy. 15: 431-8. PMID 17235323 DOI: 10.1038/sj.mt.6300047  0.76
2007 Quenneville SP, Chapdelaine P, Rousseau J, Tremblay JP. Dystrophin expression in host muscle following transplantation of muscle precursor cells modified with the phiC31 integrase Gene Therapy. 14: 514-522. PMID 17167499 DOI: 10.1038/sj.gt.3302887  0.76
2007 Mills P, Lafrenière JF, Benabdallah BF, El Fahime EM, Tremblay JP. A new pro-migratory activity on human myogenic precursor cells for a synthetic peptide within the E domain of the mechano growth factor Experimental Cell Research. 313: 527-537. PMID 17156777 DOI: 10.1016/j.yexcr.2006.10.032  0.76
2007 Skuk D, Goulet M, Roy B, Piette V, Côté CH, Chapdelaine P, Hogrel JY, Paradis M, Bouchard JP, Sylvain M, Lachance JG, Tremblay JP. First test of a "high-density injection" protocol for myogenic cell transplantation throughout large volumes of muscles in a Duchenne muscular dystrophy patient: eighteen months follow-up. Neuromuscular Disorders : Nmd. 17: 38-46. PMID 17142039 DOI: 10.1016/j.nmd.2006.10.003  0.76
2007 Bouchentouf M, Skuk D, Tremblay JP. Early and massive death of myoblasts transplanted into skeletal muscle: Responsible factors and potential solutions Current Opinion in Organ Transplantation. 12: 664-667. DOI: 10.1097/MOT.0b013e3282f19f20  0.76
2006 Tremblay JP. CSCI/RCPSC Henry Friesen lecture: Cell therapy for duchenne muscular dystrophy Clinical and Investigative Medicine. 29: 378-382. PMID 17330454  0.76
2006 Stephan L, Pichavant C, Bouchentouf M, Mills P, Camirand G, Tagmouti S, Rothstein D, Tremblay JP. Induction of tolerance across fully mismatched barriers by a nonmyeloablative treatment excluding antibodies or irradiation use Cell Transplantation. 15: 835-846. PMID 17269453  0.76
2006 Skuk D, Goulet M, Tremblay JP. Use of repeating dispensers to increase the efficiency of the intramuscular myogenic cell injection procedure. Cell Transplantation. 15: 659-63. PMID 17176617 DOI: 10.3727/000000006783981648  0.76
2006 Quenneville SP, Tremblay JP. Ex vivo modification of cells to induce a muscle-based expression Current Gene Therapy. 6: 625-632. PMID 17168695 DOI: 10.2174/156652306779010651  0.76
2006 Bouchentouf M, Benabdallah BF, Mills P, Tremblay JP. Exercise improves the success of myoblast transplantation in mdx mice Neuromuscular Disorders. 16: 518-529. PMID 16919954 DOI: 10.1016/j.nmd.2006.06.003  0.76
2006 Skuk D, Goulet M, Roy B, Chapdelaine P, Bouchard JP, Roy R, Dugré FJ, Sylvain M, Lachance JG, Deschênes L, Senay H, Tremblay JP. Dystrophin expression in muscles of duchenne muscular dystrophy patients after high-density injections of normal myogenic cells. Journal of Neuropathology and Experimental Neurology. 65: 371-86. PMID 16691118 DOI: 10.1097/01.jnen.0000218443.45782.81  0.76
2006 Chapdelaine P, Kang J, Boucher-Kovalik S, Caron N, Tremblay JP, Fortier MA. Decidualization and maintenance of a functional prostaglandin system in human endometrial cell lines following transformation with SV40 large T antigen Molecular Human Reproduction. 12: 309-319. PMID 16556676 DOI: 10.1093/molehr/gal034  0.76
2006 Lafreniere JF, Mills P, Bouchentouf M, Tremblay JP. Interleukin-4 improves the migration of human myogenic precursor cells in vitro and in vivo Experimental Cell Research. 312: 1127-1141. PMID 16466711 DOI: 10.1016/j.yexcr.2006.01.002  0.76
2006 Sanberg PR, Ricordi C, Tremblay JP, Miranda RN, SanMartin A. Online manuscript processing for cell transplantation Cell Transplantation. 15: 453. DOI: 10.3727/000000006783981738  0.76
2006 Skuk D, Tremblay JP. A historic recapitulation of myoblast transplantation Stem Cell Therapy and Tissue Engineering For Cardiovascular Repair: From Basic Research to Clinical Applications. 61-79. DOI: 10.1007/0-387-30939-X_4  0.76
2006 El Fahime E, Tremblay JP. Myocardial regeneration: Which cell and why Stem Cell Therapy and Tissue Engineering For Cardiovascular Repair: From Basic Research to Clinical Applications. 25-35. DOI: 10.1007/0-387-30939-X_2  0.76
2005 Benabdallah BF, Bouchentouf M, Tremblay JP. Improved success of myoblast transplantation in mdx mice by blocking the myostatin signal Transplantation. 79: 1696-1702. PMID 15973171 DOI: 10.1097/01.TP.0000167379.27872.2B  0.76
2005 Bouchentouf M, Benabdallah BF, Dumont M, Rousseau J, Jobin L, Tremblay JP. Real-time imaging of myoblast transplantation using the human sodium iodide symporter Biotechniques. 38: 937-942.  0.76
2004 Quenneville SP, Chapdelaine P, Rousseau J, Beaulieu J, Caron NJ, Skuk D, Mills P, Olivares EC, Calos MP, Tremblay JP. Nucleofection of muscle-derived stem cells and myoblasts with φC31 integrase: Stable expression of a full-length-dystrophin fusion gene by human myoblasts Molecular Therapy. 10: 679-687. PMID 15451452 DOI: 10.1016/j.ymthe.2004.05.034  0.76
2004 Camirand G, Rousseau J, Ducharme ME, Rothstein DM, Tremblay JP. Novel Duchenne muscular dystrophy treatment through myoblast transplantation tolerance with anti-CD45RB, anti-CD154 and mixed chimerism. American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons. 4: 1255-65. PMID 15268726 DOI: 10.1111/j.1600-6143.2004.00501.x  0.76
2004 Lafreniere JF, Mills P, Tremblay JP, El Fahime E. Growth factors improve the in vivo migration of human skeletal myoblasts by modulating their endogenous proteolytic activity Transplantation. 77: 1741-1747. PMID 15201676 DOI: 10.1097/01.TP.0000131175.60047.EB  0.76
2004 Bouchentouf M, Benabdallah BF, Tremblay JP. Myoblast survival enhancement and transplantation success improvement by heat-shock treatment in MDX mice Transplantation. 77: 1349-1356. PMID 15167589 DOI: 10.1097/01.TP.0000121503.01535.F5  0.76
2004 Caron NJ, Quenneville SP, Tremblay JP. Endosome disruption enhances the functional nuclear delivery of Tat-fusion proteins Biochemical and Biophysical Research Communications. 319: 12-20. PMID 15158435 DOI: 10.1016/j.bbrc.2004.04.180  0.76
2004 Skuk D, Roy B, Goulet M, Chapdelaine P, Bouchard JP, Roy R, Dugré FJ, Lachance JG, Deschênes L, Hélène S, Sylvain M, Tremblay JP. Dystrophin expression in myofibers of Duchenne muscular dystrophy patients following intramuscular injections of normal myogenic cells. Molecular Therapy : the Journal of the American Society of Gene Therapy. 9: 475-82. PMID 15038390 DOI: 10.1016/j.ymthe.2003.11.023  0.76
2003 Skuk D, Tremblay JP. Myoblast transplantation: The current status of a potential therapeutic tool for myopathies Journal of Muscle Research and Cell Motility. 24: 285-300. PMID 14620742  0.76
2003 Skuk D, Tremblay JP. Cell therapies for inherited myopathies Current Opinion in Rheumatology. 15: 723-729. PMID 14569201 DOI: 10.1097/00002281-200311000-00007  0.76
2003 Skuk D, Caron NJ, Goulet M, Roy B, Tremblay JP. Resetting the problem of cell death following muscle-derived cell transplantation: detection, dynamics and mechanisms. Journal of Neuropathology and Experimental Neurology. 62: 951-67. PMID 14533784  0.76
2003 Torrente Y, Camirand G, Pisati F, Belicchi M, Rossi B, Colombo F, El Fahime M, Caron NJ, Issekutz AC, Constantin G, Tremblay JP, Bresolin N. Identification of a putative pathway for the muscle homing of stem cells in a muscular dystrophy model. The Journal of Cell Biology. 162: 511-20. PMID 12885758 DOI: 10.1083/jcb.200210006  0.76
2003 El Fahime E, Bouchentouf M, Benabdallah BF, Skuk D, Lafreniere JF, Chang YT, Tremblay JP. Tubulyzine®, a novel tri-substituted triazine, prevents the early cell death of transplanted myogenic cells and improves transplantation success Biochemistry and Cell Biology. 81: 81-90. PMID 12870872 DOI: 10.1139/o03-054  0.76
2003 Di Donna S, Mamchaoui K, Cooper RN, Seigneurin-Venin S, Tremblay J, Butler-Browne GS, Mouly V. Telomerase can extend the proliferative capacity of human myoblasts, but does not lead to their immortalization Molecular Cancer Research. 1: 643-653. PMID 12861050  0.76
2003 Terrente Y, El Fahime E, Caron NJ, Del Bo R, Belicchi M, Pisati F, Tremblay JP, Bresolin N. Tumor necrosis factor-α (TNF-α) stimulates chemotactic response in mouse myogenic cells Cell Transplantation. 12: 91-100. PMID 12693669  0.76
2003 Tremblay JP. Myogenesis: Where and how can we get skeletal myoblasts? Dialogues in Cardiovascular Medicine. 8: 137-142.  0.76
2002 Skuk D, Caron N, Goulet M, Roy B, Espinosa F, Tremblay JP. Dynamics of the early immune cellular reactions after myogenic cell transplantation. Cell Transplantation. 11: 671-81. PMID 12518894  0.76
2002 Skuk D, Goulet M, Roy B, Tremblay JP. Efficacy of myoblast transplantation in nonhuman primates following simple intramuscular cell injections: toward defining strategies applicable to humans. Experimental Neurology. 175: 112-26. PMID 12009764 DOI: 10.1006/exnr.2002.7899  0.76
2002 Camirand G, Caron NJ, Turgeon NA, Rossini AA, Tremblay JP. Treatment with anti-CD154 antibody and donor specific transfusion prevents acute rejection of myoblast transplantation Transplantation. 73: 453-461. PMID 11884944 DOI: 10.1097/00007890-200202150-00021  0.76
2002 Leriche-Guérin K, Anderson LV, Wrogemann K, Roy B, Goulet M, Tremblay JP. Dysferlin expression after normal myoblast transplantation in SCID and in SJL mice. Neuromuscular Disorders : Nmd. 12: 167-73. PMID 11738359 DOI: 10.1016/S0960-8966(01)00254-1  0.76
2000 Moisset PA, Bonham L, Skuk D, Koeberl D, Brussee V, Goulet M, Roy B, Asselin I, Miller AD, Tremblay JP. Systemic production of human granulocyte colony-stimulating factor in nonhuman primates by transplantation of genetically modified myoblasts. Human Gene Therapy. 11: 1277-88. PMID 10890738 DOI: 10.1089/10430340050032384  0.76
2000 Seigneurin-Venin S, Bernard V, Tremblay JP. Telomerase allows the immortalization of T antigen-positive DMD myoblasts: A new source of cells for gene transfer application Gene Therapy. 7: 619-623. PMID 10819578 DOI: 10.1038/sj.gt.3301132  0.76
2000 Skuk D, Goulet M, Roy B, Tremblay JP. Myoblast transplantation in whole muscle of nonhuman primates. Journal of Neuropathology and Experimental Neurology. 59: 197-206. PMID 10744058 DOI: 10.1093/jnen/59.3.197  0.76
1999 Vilquin JT, Guérette B, Puymirat J, Yaffe D, Tomé FMS, Fardeau M, Fiszman M, Schwartz K, Tremblay JP. Myoblast transplantations lead to the expression of the laminin α2 chain in normal and dystrophic (dy/dy) mouse muscles Gene Therapy. 6: 792-800. PMID 10505103 DOI: 10.1038/sj.gt.3300889  0.76
1999 Skuk D, Furling D, Bouchard JP, Goulet M, Roy B, Lacroix Y, Vilquin JT, Tremblay JP, Puymirat J. Transplantation of human myoblasts in SCID mice as a potential muscular model for myotonic dystrophy. Journal of Neuropathology and Experimental Neurology. 58: 921-31. PMID 10499435 DOI: 10.1097/00005072-199909000-00003  0.76
1999 Brussee V, Tardif F, Roy B, Goulet M, Sebille A, Tremblay JP. Successful myoblast transplantation in fibrotic muscles: no increased impairment by the connective tissue. Transplantation. 67: 1618-22. PMID 10401771 DOI: 10.1097/00007890-199906270-00018  0.76
1997 Guérette B, Moisset PA, Huard C, Tardif F, Gravel C, Tremblay JP. Inflammatory damage following first-generation replication-defective adenovirus controlled by anti-LFA-1. Journal of Leukocyte Biology. 61: 533-8. PMID 9103242 DOI: 10.1002/jlb.61.4.533  0.76
1996 Guérette B, Vilquin JT, Gingras M, Gravel C, Wood KJ, Tremblay JP. Prevention of immune reactions triggered by first-generation adenoviral vectors by monoclonal antibodies and CTLA4Ig. Human Gene Therapy. 7: 1455-63. PMID 8844205 DOI: 10.1089/hum.1996.7.12-1455  0.76
1996 Kinoshita I, Roy R, Dugré FJ, Gravel C, Roy B, Goulet M, Asselin I, Tremblay JP. Myoblast transplantation in monkeys: control of immune response by FK506. Journal of Neuropathology and Experimental Neurology. 55: 687-97. PMID 8642394 DOI: 10.1097/00005072-199606000-00002  0.76
1995 Vilquin JT, Guérette B, Kinoshita I, Roy B, Goulet M, Gravel C, Roy R, Tremblay JP. FK506 immunosuppression to control the immune reactions triggered by first-generation adenovirus-mediated gene transfer. Human Gene Therapy. 6: 1391-401. PMID 8573612 DOI: 10.1089/hum.1995.6.11-1391  0.76
1994 Huard J, Roy R, Guérette B, Verreault S, Tremblay G, Tremblay JP. Human myoblast transplantation in immunodeficient and immunosuppressed mice: evidence of rejection. Muscle & Nerve. 17: 224-34. PMID 8114793 DOI: 10.1002/mus.880170214  0.76
1994 Huard J, Verreault S, Roy R, Tremblay M, Tremblay JP. High efficiency of muscle regeneration after human myoblast clone transplantation in SCID mice. The Journal of Clinical Investigation. 93: 586-99. PMID 8113396 DOI: 10.1172/JCI117011  0.76
1994 Kinoshita I, Huard J, Tremblay JP. Utilization of myoblasts from transgenic mice to evaluate the efficacy of myoblast transplantation Muscle and Nerve. 17: 975-980. PMID 8065399 DOI: 10.1002/mus.880170903  0.76
1993 Satoh A, Huard J, Labrecque C, Tremblay JP. Use of fluorescent latex microspheres (FLMs) to follow the fate of transplanted myoblasts Journal of Histochemistry and Cytochemistry. 41: 1579-1582. PMID 8245416 DOI: 10.1177/41.10.8245416  0.76
1993 Huard J, Tremblay G, Verreault S, Labrecque C, Tremblay JP. Utilization of an antibody specific for human dystrophin to follow myoblast transplantation in nude mice. Cell Transplantation. 2: 113-8. PMID 8143077 DOI: 10.1177/096368979300200204  0.76
1992 Huard J, Tremblay JP. Localization of dystrophin in the Purkinje cells of normal mice Neuroscience Letters. 137: 105-108. PMID 1625810 DOI: 10.1016/0304-3940(92)90309-U  0.76
1992 Huard J, Fortier LP, Dansereau G, Labrecque C, Tremblay JP. A light and electron microscopic study of dystrophin localization at the mouse neuromuscular junction Synapse. 10: 83-93. PMID 1585259 DOI: 10.1002/syn.890100202  0.76
1992 Huard J, Satoh A, Tremblay JP. Mosaic expression of dystrophin in the cerebellum of heterozygote dystrophic (mdx) mice Neuromuscular Disorders. 2: 311-321. PMID 1300180 DOI: 10.1016/S0960-8966(06)80002-7  0.76
1992 Huard J, Côté PY, Parent A, Bouchard JP, Tremblay JP. Dystrophin-like immunoreactivity in monkey and human brain areas involved in learning and motor functions Neuroscience Letters. 141: 181-186. PMID 1279470 DOI: 10.1016/0304-3940(92)90890-J  0.76
1991 Huard J, Fortier LP, Labrecque C, Dansereau G, Tremblay JP. Is dystrophin present in the nerve terminal at the neuromuscular junction? An immunohistochemical study of the heterozygote dystrophic (mdx) mouse Synapse. 7: 135-140. PMID 2011828 DOI: 10.1002/syn.890070207  0.76
1991 Huard J, Labrecque C, Dansereau G, Robitaille L, Tremblay JP. Dystrophin expression in myotubes formed by the fusion of normal and dystrophic myoblasts. Muscle & Nerve. 14: 178-82. PMID 2000106 DOI: 10.1002/mus.880140213  0.76
1991 Labrecque C, Huard J, Dansereau G, Albert N, Tremblay JP. In vitro bromodeoxyuridine labeling of nuclei: Application to myotube hybridization Journal of Histochemistry and Cytochemistry. 39: 1421-1426. PMID 1940314 DOI: 10.1177/39.10.1940314  0.76
1991 Labrecque C, Huard J, Dansereau G, Robitaille L, Tremblay JP. A new technique to identify hybrid myotubes in vitro without culture fixation. The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society. 39: 139-43. PMID 1701185 DOI: 10.1177/39.1.1701185  0.76
1991 Robitaille R, Tremblay JP. Non-uniform responses to Ca2+ along the frog neuromuscular junction: effects on the probability of spontaneous and evoked transmitter release. Neuroscience. 40: 571-85. PMID 1674115 DOI: 10.1016/0306-4522(91)90142-B  0.76
1990 Fortier LP, Tremblay JP. Postsynaptic structure may account for variations in miniature endplate current shapes along frog neuromuscular junctions Synapse. 5: 255-264. PMID 2360195 DOI: 10.1002/syn.890050402  0.76
1989 Robitaille R, Tremblay JP. Frequency and amplitude gradients of spontaneous release along the length of the frog neuromuscular junction. Synapse (New York, N.Y.). 3: 291-307. PMID 2568018 DOI: 10.1002/syn.890030402  0.76
1989 Tremblay JP, Robitaille R, Martineau O, Labrecque C, Fahim MA. Proximodistal gradients of the postjunctional folds at the frog neuromuscular junction: a scanning electron microscopic study. Neuroscience. 30: 535-50. PMID 2546099 DOI: 10.1016/0306-4522(89)90271-6  0.76
1987 Robitaille R, Tremblay JP, Grenon G. Non-uniform distribution of miniature endplate potential amplitudes along the length of the frog neuromuscular junction. Neuroscience Letters. 74: 187-92. PMID 3494962 DOI: 10.1016/0304-3940(87)90147-9  0.76
1987 Robitaille R, Tremblay JP. Incorporation of vesicular antigens into the presynaptic membrane during exocytosis at the frog neuromuscular junction: a light and electron microscopy immunochemical study. Neuroscience. 21: 619-29. PMID 3039406 DOI: 10.1016/0306-4522(87)90147-3  0.76
1987 Robitaille R, Tremblay JP, Grenon G. Interrelation between MEPP amplitude and MEPP frequency in different regions along the frog neuromuscular junction. Brain Research. 408: 353-8. PMID 3036304 DOI: 10.1016/0006-8993(87)90404-5  0.76
1987 Robitaille R, Tremblay JP. Non-uniform release at the frog neuromuscular junction: evidence of morphological and physiological plasticity. Brain Research. 434: 95-116. PMID 2882823 DOI: 10.1016/0165-0173(87)90019-1  0.76
1985 Tremblay JP, Robitaille R, Grenon G. Miniature endplate potential amplitudes corrected for spatial decay are not normally distributed. Brain Research. 328: 170-5. PMID 3871653 DOI: 10.1016/0006-8993(85)91339-3  0.76
1985 Tremblay JP, Gravel C, Hawkes RB. A monoclonal antibody to beta-tubulin distinguishes a subset of neurons and axons in the chick ciliary ganglion. Canadian Journal of Biochemistry and Cell Biology = Revue Canadienne De Biochimie Et Biologie Cellulaire. 63: 458-69. PMID 2412671 DOI: 10.1139/o85-065  0.76
1984 Tremblay JP, Robitaille R, Grenon G. Distribution of spontaneous release along the frog neuromuscular junction. Neuroscience Letters. 51: 247-52. PMID 6151156 DOI: 10.1016/0304-3940(84)90559-7  0.76
1983 Tremblay JP, Laurie RE, Colonnier M. Is the MEPP due to the release of one vesicle or to the simultaneous release of several vesicles at one active zone? Brain Research Reviews. 6: 299-314. DOI: 10.1016/0165-0173(83)90009-7  0.76
1982 Laurie RE, Tremblay JP. Boutons originating from the same axon do not participate equally in synaptic transmission Neuroscience Letters. 29: 135-140. PMID 6283435 DOI: 10.1016/0304-3940(82)90342-1  0.76
1980 Tremblay JP, Grenon G, Plourde G. The effects of hemicholinium-3 on synaptic depression, facilitation, and post-tetanic potentiation at an identified synapse of Aplysia californica. Canadian Journal of Physiology and Pharmacology. 58: 373-83. PMID 7388688 DOI: 10.1139/y80-064  0.76
1979 Colonnier M, Tremblay JP, McLennan H. Synaptic contacts on glial cells in the abdominal ganglion of Aplysia californica. The Journal of Comparative Neurology. 188: 391-400. PMID 573764 DOI: 10.1002/cne.901880304  0.76
1979 Tremblay JP, Colonnier M, McLennan H. An electron microscope study of synaptic contacts in the abdominal ganglion of Aplysia californica. The Journal of Comparative Neurology. 188: 367-89. PMID 489800 DOI: 10.1002/cne.901880303  0.76
1977 Tremblay JP, Plourde G. Presynaptic modulating effects of GABA on depression, facilitation, and posttetanic potentiation of a cholinergic synapse in Aplysia californica. Canadian Journal of Physiology and Pharmacology. 55: 1286-301. PMID 597779 DOI: 10.1139/y77-174  0.76
1976 Woodson PB, Tremblay JP, Schlapfer WT, Barondes SH. Heterosynaptic inhibition modifies the presynaptic plasticities of the transmission process at the synapse in Aplysia californica. Brain Research. 109: 83-95. PMID 179668 DOI: 10.1016/0006-8993(76)90381-4  0.76
1976 Tremblay JP, Woodson PB, Schlapfer WT, Barondes SH. Dopamine, serotonin and related compounds: presynaptic effects on synaptic depression, frequency facilitation, and post-tetanic potentiation at a synapse in Aplysia californica. Brain Research. 109: 61-81. PMID 179667 DOI: 10.1016/0006-8993(76)90380-2  0.76
1976 Schlapfer WT, Tremblay JP, Woodson PB, Barondes SH. Frequency facilitation and post-tetanic potentiation of a unitary synaptic potential in Aplysia californica are limited by different processes. Brain Research. 109: 1-20. PMID 179665 DOI: 10.1016/0006-8993(76)90377-2  0.76
1976 Woodson PB, Schlapfer WT, Tremblay JP, Barondes SH. Synaptic depression at a synapse in Aplysia californica: analysis in terms of a material flow model of neurotransmitter. Brain Research. 109: 41-59. PMID 6120 DOI: 10.1016/0006-8993(76)90379-6  0.76
1976 Woodson PB, Schlapfer WT, Tremblay JP, Barondes SH. Resting and stimulated values of model parameters governing transmitter release at a synapse in Aplysia californica. Brain Research. 109: 21-40. PMID 6119 DOI: 10.1016/0006-8993(76)90378-4  0.76
1975 Woodson PB, Schlapfer WT, Tremblay JP, Barondes SH. Cholinergic agents affect two receptors that modulate transmitter release at a central synapse in Aplsia californica. Brain Research. 88: 455-74. PMID 166727 DOI: 10.1016/0006-8993(75)90657-5  0.76
1975 Schlapfer WT, Woodson PB, Smith GA, Tremblay JP, Barondes SH. Marked prolongation of post-tetanic potentiation at a transition temperature in its adaption. Nature. 258: 623-5. PMID 1679 DOI: 10.1038/258623a0  0.76
1974 Tremblay JP, Schlapfer WT, Woodson PB, Barondes SH. Morphine and related compounds: evidence that they decrease available neurotransmitter in Aplysia californica. Brain Research. 81: 107-18. PMID 4373124 DOI: 10.1016/0006-8993(74)90481-8  0.76
1974 Schlapfer WT, Woodson PB, Tremblay JP, Barondes SH. Depression and frequency facilitation at a synapse in Aplysia californica: evidence for regulation by availability of transmitter. Brain Research. 76: 267-80. PMID 4367505 DOI: 10.1016/0006-8993(74)90459-4  0.76
1974 Tremblay J, Simon M, Barondes SH. Cerebroside may be falsely identified as a soluble 'brain specific protein'. Journal of Neurochemistry. 23: 315-8. PMID 4213700  0.76
Show low-probability matches.